EUROFINS SCIENTIFIC (ERF.PA) Stock Overview
EPA:ERF - FR0014000MR3 - Common Stock
ERF.PA Key Statistics, Chart & Performance
The current stock price of ERF.PA is 63.84 EUR. In the past month the price decreased by -3.94%. In the past year, price increased by 21.05%.
ERF.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 22.38 | 158.80B | ||
| DAP.DE | DANAHER CORP | 26.45 | 122.53B | ||
| LO3.DE | LONZA GROUP AG-REG | 37.29 | 43.26B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 42.92 | 17.25B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 42.07 | 16.91B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 44.4 | 14.46B | ||
| ILU.DE | ILLUMINA INC | 23.47 | 12.88B | ||
| SRT.DE | SARTORIUS AG | 36.32 | 11.83B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 17.66 | 11.58B | ||
| QIA.DE | QIAGEN N.V. | 20.09 | 8.76B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 22.37 | 3.27B | ||
| TEN.DE | TECAN GROUP AG-REG | 31.61 | 2.15B |
Related stock screener links
About ERF.PA
Company Profile
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and, consumer products industries and to governments. The company operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.
Company Info
EUROFINS SCIENTIFIC
23 Val Fleuri
Luxembourg LU
Employees: 62696
Phone: 35226185320
EUROFINS SCIENTIFIC / ERF.PA FAQ
What is the stock price of EUROFINS SCIENTIFIC today?
The current stock price of ERF.PA is 63.84 EUR. The price increased by 1.69% in the last trading session.
What is the ticker symbol for EUROFINS SCIENTIFIC stock?
The exchange symbol of EUROFINS SCIENTIFIC is ERF and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ERF.PA stock listed?
ERF.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for EUROFINS SCIENTIFIC stock?
18 analysts have analysed ERF.PA and the average price target is 64.9 EUR. This implies a price increase of 1.65% is expected in the next year compared to the current price of 63.84. Check the EUROFINS SCIENTIFIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EUROFINS SCIENTIFIC worth?
EUROFINS SCIENTIFIC (ERF.PA) has a market capitalization of 11.63B EUR. This makes ERF.PA a Large Cap stock.
How many employees does EUROFINS SCIENTIFIC have?
EUROFINS SCIENTIFIC (ERF.PA) currently has 62696 employees.
What are the support and resistance levels for EUROFINS SCIENTIFIC (ERF.PA) stock?
EUROFINS SCIENTIFIC (ERF.PA) has a support level at 63.83 and a resistance level at 68.76. Check the full technical report for a detailed analysis of ERF.PA support and resistance levels.
Is EUROFINS SCIENTIFIC (ERF.PA) expected to grow?
The Revenue of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 5.88% in the next year. Check the estimates tab for more information on the ERF.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EUROFINS SCIENTIFIC (ERF.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ERF.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ERF.PA, evaluating the profitability, health, valuation and growth aspects
- EUROFINS SCIENTIFIC (ERF.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EUROFINS SCIENTIFIC (ERF.PA) Sales and EPS estimates to see what analysts future expectations are.
- EUROFINS SCIENTIFIC (ERF.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EUROFINS SCIENTIFIC (ERF.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- EUROFINS SCIENTIFIC (ERF.PA) Stock Chart to make your own analysis
- EUROFINS SCIENTIFIC (ERF.PA) Latest news and press-releases to stay up to date.
Does EUROFINS SCIENTIFIC (ERF.PA) stock pay dividends?
EUROFINS SCIENTIFIC (ERF.PA) has a dividend yield of 0.96%. The yearly dividend amount is currently 0.52. Check the full fundamental report for a detailed analysis of ERF.PA dividend history, reliability and sustainability.
When does EUROFINS SCIENTIFIC (ERF.PA) report earnings?
EUROFINS SCIENTIFIC (ERF.PA) will report earnings on 2025-10-21.
What is the Price/Earnings (PE) ratio of EUROFINS SCIENTIFIC (ERF.PA)?
The PE ratio for EUROFINS SCIENTIFIC (ERF.PA) is 17.73. This is based on the reported non-GAAP earnings per share of 3.6 and the current share price of 63.84 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ERF.PA.
ERF.PA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ERF.PA. When comparing the yearly performance of all stocks, ERF.PA is one of the better performing stocks in the market, outperforming 79.57% of all stocks.
ERF.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ERF.PA. ERF.PA has an excellent profitability rating, but there are some minor concerns on its financial health.
ERF.PA Financial Highlights
Over the last trailing twelve months ERF.PA reported a non-GAAP Earnings per Share(EPS) of 3.6. The EPS increased by 16.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.44% | ||
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| Debt/Equity | 0.77 |
ERF.PA Forecast & Estimates
18 analysts have analysed ERF.PA and the average price target is 64.9 EUR. This implies a price increase of 1.65% is expected in the next year compared to the current price of 63.84.
For the next year, analysts expect an EPS growth of 13.37% and a revenue growth 5.88% for ERF.PA